First Trust Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.55M | Buy |
|
|||||
|
2025
Q1 | $3.39M | Sell |
|
|||||
|
2024
Q4 | $3.57M | Sell |
|
|||||
|
2024
Q3 | $3.54M | Buy |
|
|||||
|
2024
Q2 | $2.68M | Buy |
|
|||||
|
2024
Q1 | $1.51M | Sell |
|
|||||
|
2023
Q4 | $1.52M | Buy |
|
|||||
|
2023
Q3 | $1.08M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1.25M | Buy |
|
|||||
|
2022
Q4 | $286K | Sell |
|
|||||
|
2022
Q3 | $947K | Sell |
|
|||||
|
2022
Q2 | $1.23M | Buy |
|
|||||
|
2022
Q1 | $894K | Buy |
|
|||||
|
2021
Q4 | $660K | Sell |
|
|||||
|
2021
Q3 | $1.75M | Sell |
|
|||||
|
2021
Q2 | $4.21M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $605K | Sell |
|
|||||
|
2020
Q3 | $1.85M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $2.79M | Sell |
|
|||||
|
2018
Q3 | $7.89M | Buy |
|
|||||
|
2018
Q2 | $4.71M | Buy |
|
|||||
|
2018
Q1 | $2.07M | Buy |
|
|||||
|
2017
Q4 | $1.71M | Buy |
|
|||||
|
2017
Q3 | $1.62M | Buy |
|
|||||
|
2017
Q2 | $524K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $2.18M | Buy |
|
|||||
|
2016
Q2 | $2.01M | Sell |
|
|||||
|
2016
Q1 | $2.15M | Sell |
|
|||||
|
2015
Q4 | $2.21M | Sell |
|
|||||
|
2015
Q3 | $2.83M | Sell |
|
|||||
|
2015
Q2 | $3.64M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $1.17M | Sell |
|
|||||
|
2014
Q2 | $2.28M | Sell |
|
|||||
|
2014
Q1 | $2.6M | Buy |
|